ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Purine → beta,gamma-Methylene ATP

HRID 363340
ノート
印刷プレビュー

反応式

HRID 363340 の反応式
N1C=C2C(N=CN2)=NC=1.[P:10]([O:22][CH2:23][C@H:24]1[O:28][C@@H:27]([N:29]2[C:38]3[N:37]=[CH:36][N:35]=[C:33]([NH2:34])[C:32]=3[N:31]=[CH:30]2)[C@H:26]([OH:39])[C@@H:25]1[OH:40])(OP(OP(O)(O)=O)(O)=O)(=[O:12])[OH:11].[P:41]([O:49][CH2:50][C@H:51]1[O:55][C@@H:54]([N:56]2[C:65]3[N:64]=[CH:63][N:62]=[C:60]([NH2:61])[C:59]=3[N:58]=[CH:57]2)[C@H:53]([OH:66])[C@@H:52]1[OH:67])([O:44][P:45]([OH:48])([OH:47])=[O:46])(=[O:43])[OH:42].[P:68]([O:72][CH2:73][C@H]1O[C@@H](N2C3N=CN=C(N)C=3N=C2)[C@H](O)[C@@H]1O)(O)([OH:70])=[O:69].[C@@H:91]1(N2C3N=CN=C(N)C=3N=C2)O[C@H](CO)[C@@H](O)[C@H]1O>>[CH:36]1[N:35]=[C:33]([NH2:34])[C:32]2[N:31]=[CH:30][N:29]([C@@H:27]3[O:28][C@H:24]([CH2:23][O:22][P:10]([OH:11])([CH2:73][P:41]([O:44][P:45]([OH:48])([OH:47])=[O:46])([OH:42])=[O:43])=[O:12])[C@@H:25]([OH:40])[C@H:26]3[OH:39])[C:38]=2[N:37]=1.[CH:63]1[N:62]=[C:60]([NH2:61])[C:59]2[N:58]=[CH:57][N:56]([C@@H:54]3[O:55][C@H:51]([CH2:50][O:49][P:41]([O:44][P:45]([OH:47])([CH2:91][P:68]([OH:72])([OH:70])=[O:69])=[O:46])([OH:42])=[O:43])[C@@H:52]([OH:67])[C@H:53]3[OH:66])[C:65]=2[N:64]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 5

HCID 1044PurineHCID 59575'-AtpHCID 60225'-AdpHCID 6083Adenosine MonophosphateHCID 60961Adenosine

生成物 2

HCID 91532beta,gamma-Methylene ATP
HCID 91557
alpha,beta-Methylene-ATP

実験手順

Purine compounds (ATP, adenosine 5'-diphosphate (ADP), adenosine 5'-monophosphate (AMP) and adenosine; 3-6 μmol kg-1 and capsaicin (10 μg kg-1) were given as a rapid bolus into the right atrium (5 ml test solution+5 ml physiological saline flush) or the right pulmonary artery (1 ml test solution+3 ml physiological saline flush). When given in the latter site, smaller doses were used, i.e. 0.5-3 μmol kg-1 for purine compounds and 1-5 μg kg-1 for capsaicin. α,β-Methylene ATP (α,β-mATP) and β,γ-methylene ATP (β,γ-mATP) were give as one low dose only (0.75 μmol kg-1) to avoid systemic side effects. Volume controls consisted of either 5+5 ml or 1+3 ml physiological saline. All injections were performed in the same mode by the same person. To exclude involvement of baroreceptors in the recorded neural activity, the latter was monitored before and after a bolus of nitroglycerine (1mg, I.V.; n=5). The effect of ganglionic transmission blockade on the effects of ATP and capsaicin was determined by the administration of hexamethonium (10 mg kg-1, I.V.; n=7).

後処理

  1. custom3-6 μmol kg-1 and capsaicin (10 μg kg-1) were given as a rapid bolus into the right atrium (5 ml test solution+5 ml physiological saline flush)
  2. customthe right pulmonary artery (1 ml test solution+3 ml physiological saline flush)

出典と根拠

ORDレコード
ord-a671929f76e2424f9c07f304075d24c3
出典データセット
uspto-grants-1999_02
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05874420

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート